IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Debt Components
- 2026-03-31: Notes Payable, CurrentUSD $1.00M; Secured Debt, CurrentUSD (m); Convertible Notes Payable, CurrentUSD (m); Senior NotesUSD (m).
- 2025-12-31: Notes Payable, CurrentUSD $1.00M; Secured Debt, CurrentUSD (m); Convertible Notes Payable, CurrentUSD (m); Senior NotesUSD (m).
- 2025-09-30: Notes Payable, CurrentUSD $1.00M; Secured Debt, CurrentUSD (m); Convertible Notes Payable, CurrentUSD (m); Senior NotesUSD (m).
- 2025-06-30: Notes Payable, CurrentUSD $1.00M; Secured Debt, CurrentUSD (m); Convertible Notes Payable, CurrentUSD (m); Senior NotesUSD (m).
IOVANCE BIOTHERAPEUTICS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable, Current USD | Secured Debt, Current USD | Convertible Notes Payable, Current USD | Senior Notes USD | Notes Payable USD | Debt Instrument, Convertible, Beneficial Conversion Feature USD | Debt Instrument, Convertible, Conversion Price USD/shares | Debt Instrument, Decrease, Forgiveness USD | Debt Instrument, Unamortized Discount USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $1.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $1.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $1.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $1.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $1.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 78 month · $18.14K | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 73 month · $18.14K | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) |
| 2013-12-31 | (m) | $0.00 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 72 month · $18.14K | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 69 month · $18.14K | (m) |
| 2013-05-22 | (m) | (m) | (m) | (m) | $9.27M | (m) | 1.00 | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 66 month · $18.14K | (m) |
| 2013-03-31 | (m) | $250.00K | $5.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) |
| 2012-12-31 | (m) | $250.00K | $5.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 64 month · $18.14K | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 60 month · $18.14K | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | 9 month · $2.21M | (m) | 9 month · $0.00 | (m) |
| 2012-09-30 | (m) | $250.00K | $5.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 57 month · $18.14K | (m) |
| 2012-06-30 | (m) | (m) | $5.00M | $250.00K | (m) | (m) | (m) | (m) | $497.89K |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $0.00 | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 54 month · $18.14K | (m) |
| 2012-03-31 | (m) | (m) | $5.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | 12 month · $177.26K | (m) | 12 month · $0.00 | (m) |
| 2011-12-31 | (m) | (m) | $5.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 51 month · $18.14K | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $0.00 | (m) |
| 2011-09-30 | (m) | (m) | $2.60M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 45 month · $642.30K | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $642.30K | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $0.00 | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $18.14K | (m) |
| 2010-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $0.00 | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |